ArticlePharmaceuticals (Basel, Switzerland)2025

A Pyrimidine-Based Tubulin Inhibitor Shows Potent Anti-Glioblastoma Activity In Vitro and In Vivo.

Satyanarayana Pochampally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.